Cargando…
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
Autores principales: | Baniandrés-Rodríguez, Ofelia, Vilar-Alejo, Jaime, Rivera, Raquel, Carrascosa, José Manuel, Daudén, Esteban, Herrera-Acosta, Enrique, Sahuquillo-Torralba, Antonio, Gómez-García, Fran J., Nieto-Benito, Lula María, de la Cueva, Pablo, López-Estebaranz, José Luis, Belinchón, Isabel, Ferrán Farrés, Marta, Alsina, Mercè, Fernández-Freire, Lourdes Rodríguez, Carretero, Gregorio, García-Donoso, Carmen, Ballescá, Ferrán, Llamas-Velasco, Mar, Herrera-Ceballos, Enrique, Botella-Estrada, Rafael, Ruiz-Genao, Diana Patricia, Riera-Monroig, Josep, Descalzo Gallego, Miguel Ángel, García-Doval, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587130/ https://www.ncbi.nlm.nih.gov/pubmed/33122022 http://dx.doi.org/10.1016/j.jaad.2020.10.046 |
Ejemplares similares
-
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort
por: HERNÁNDEZ-FERNÁNDEZ, Carlos Pelayo, et al.
Publicado: (2021) -
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain
por: Daudén, Esteban, et al.
Publicado: (2021) -
Polymorphisms Associated with Age at Onset in Patients with
Moderate-to-Severe Plaque Psoriasis
por: Prieto-Pérez, Rocío, et al.
Publicado: (2015) -
Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review
por: Belinchon Romero, Isabel, et al.
Publicado: (2023) -
Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document
por: Belinchón Romero, Isabel, et al.
Publicado: (2021)